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ABSTRACT
Natural oligopeptides may regulate nearly all vital
processes. To date, the chemical structures of
nearly 6000 oligopeptides have been identified from
.1000 organisms representing all the biological
kingdoms. We have compiled the known physical,
chemical and biological properties of these
oligopeptides—whether synthesized on ribosomes
orbynon-ribosomalenzymes—andhaveconstructed
an internet-accessible database, EROP-Moscow
(Endogenous Regulatory OligoPeptides), which
resides at http://erop.inbi.ras.ru. This database
enables users to perform rapid searches via many
key features of the oligopeptides, and to carry out
statistical analysis of all the available information.
The database lists only those oligopeptides whose
chemical structures have been completely deter-
mined (directly or by translation from nucleotide
sequences). It provides extensive links with the
Swiss-Prot-TrEMBL peptide-protein database, as
well as with the PubMed biomedical bibliographic
database. EROP-Moscow also contains data on
many oligopeptides that are absent from other con-
venient databases, and is designed for extended
use in classifying new natural oligopeptides and for
production of novel peptide pharmaceuticals.
INTRODUCTION
For more than a century, natural oligopeptides have attracted
scientiﬁc attention (1) as biochemical regulators. The very
ﬁrst such oligopeptide, carnosine (b-ala-his), was discovered
by Gulevitch and Amiradzhibi in 1900 (2), but its chemical
structure was not determined until 1918 (3). Since that time,
thousands oligopeptide regulators have been described, and
now  500 new natural oligopeptides emerge annually, out of
a literature of >20000 publications each year on oligopeptide
chemistry and biology.
Regulatory oligopeptides generally do not exceed  50
amino acid residues (4), and they differ substantially from
larger polypeptides (proteins) in their physicochemical and
biological properties. Speciﬁcally, the smaller peptides rarely
possess strong enough intramolecular attractions to form
stable globules (5), so they are able to shift conﬁgurations
(6) and to ﬁt themselves into speciﬁc receptor molecules, a
process which is further aided by high diffusional mobility (7).
The terms ‘natural’ oligopeptide and ‘regulatory’ oligo-
peptide can be considered synonymous. Few integrated bio-
logical processes are knownwhich are notregulated,or atleast
modulated, by small peptides. Such roles are especially well
known in the regulatory organ systems, viz. nervous, endo-
crine and immune systems (1), but their functions extend well
beyond the bounds of single organ systems or even of single
biological species. Antimicrobial oligopeptides produced by
prokaryotes themselves, for example, regulate competition for
ecological niches and simultaneously function as signaling
molecules for species-speciﬁc intercellular communication
(8). And even eukaryotic oligopeptide toxins seem to play
important roles in regulating interspecies reactions (9).
It has been clear for >15 years that detailed understanding
of the complex regulatory processes involving oligopeptides
requires a system for classifying these molecules and for
cataloguing their major properties. Our ﬁrst attempt at such
a system, in 1991 (4,10), yielded the MS-DOS version of
EROP-Moscow, which contained structures, functions and
sources of the oligopeptides then known. That database, how-
ever, was not widely accessible to the research community.
In the meanwhile, a number of extensive and highly utilized
peptide–protein databases have been created (e.g. Swiss-
Prot-TrEMBL), but their data on small natural peptides is
far from comprehensive and constitutes only a small fraction
of their total information, so that retrieving relevant oli-
gopeptide data from them can be laborious and excessively
time-consuming period.
Here we present an internet version of the compact
specialized database EROP-Moscow, recreated to provide a
comprehensive description of all presently known natural oli-
gopeptides. Neuropeptides, peptide hormones, antimicrobial
agents and toxins represent the largest functional classes.
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for oligopeptides via a wide variety of different features, to
compare their properties quickly, and to retrieve statistics
about all relevant information in the database.
INFORMATION SOURCES
Since the objectives of an internet version of EROP-Moscow
are to collect and disseminate all essential information about
currently known oligopeptides, authenticity is of paramount
importance. Therefore, all information in this database has
been extracted directly from the primary sources, the great
majority of which are publications in scientiﬁc journals. More
than 100 journals in biochemistry, biophysics, physiology,
genetics and general biology are being continuously screened
and descriptions of the structures of newly found natural
oligopeptides are being retrieved. In many of these articles,
the authors compare the novel structures with known ones
and provide references to publications not included in our
systematic screening. Such publications then become an addi-
tional source of primary information for the EROP-Moscow.
Finally, initial reports on novel oligopeptides are sometimes
found in book chapters, patent descriptions and other protein-
peptide databases, and these sources are used, as well, and
are appropriately documented. The total number of useful
sources for basic information on natural oligopeptides is
now >250.
In addition to the client–server features of EROP-Moscow,
alibraryofpublicationshasbeen created,containingthe actual
primary descriptions of oligopeptides, along with their pdf
ﬁles.
SELECTION OF OLIGOPEPTIDES
Only those oligopeptides are entered into EROP-Moscow,
whose chemical structures have been completely determined
(either directly or by translation from nucleotide sequences),
and can be described by the standard single-letter amino
acid code. Although most peptides included in this version
of EROP-Moscow are formed by ribosomal synthesis, a small
number formed by non-ribosomal enzymes (11)—mostly
from bacteria and fungi—are also included, provided they
comprise residues ﬁtting the standard one-letter code. Oli-
gopeptides with still ambiguous structures, such as aspar-
agine/aspartic acid or glutamine/glutamic acid at single
residues, have been deliberately excluded from this database,
as have artiﬁcially synthesized molecules that are not found
in nature.
ORGANIZATION OF EROP-MOSCOW
The EROP-Moscow database presents multilevel bioinforma-
tion via an HTML-based interface. This interface includes:
Home page, Query page, Peptide page, Results page, Family
page and Statistics pages (Figure 1). All of these pages contain
internal EROP-Moscow links (including Home page, Site
map, Contact us and Help) as well as links to external data-
bases such as Swiss-Prot, Protein Identiﬁcation Resource
(PIR), PDB and PubMed.
The following programming elements, freely available on
the basis of the GNU License, have been used as server soft-
ware, and these are updated as new versions appear.
(i) MySQL database server, version 4.0.14-max;
Figure 1. EROP-Moscow architecture illustrated on the Site Map page.
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support;
(iii) PHP language, version 4.0;
(iv) Remote management server with the HTML interface
WebMin, version 1.0.70.
The basic operational unit of EROP-Moscow is an entry
(¼ record). Each individual entry describes the physical,
chemical and biological characteristics of one unique natural
oligopeptide. Each entry is tagged by a unique accession
number, beginning with character ‘E’ (from EROP) followed
by ﬁve numerical digits.
Individual sequences which are found in multiple organ-
isms, even taxonomically remote ones, are presented only
once in EROP-Moscow, with the names of all known organ-
isms possessing that oligopeptide being suspended.
On the other hand, oligopeptides existing in two or more
distinct chemical modiﬁcations (usually accompanied by
clear functional differences) are registered as separate entries
and are assigned distinct names and accession numbers.
Good examples of this are two natural chemical forms of
gastrin: one having a simple tyrosine residue and the other,
a sulfated tyrosine residue (12).
Home page
Users would normally enter EROP-Moscow via the site
address http://erop.inbi.ras.ru. The Home page lists various
information about the database itself, including the date
of the most recent version, the current number of entries,
on-going changes in the content (EROP-news), the list of
database authors and some descriptive information. Home
page is linked to the Query page and to Statistics pages for
individual peptides. A Contact-us button facilitates ordinary
E-mail messages and inqueries to the database manager.
Query page
The Query page, entered from Home page via the ‘Query
page’ button, provides a rapid search for the peptide records
signaled by speciﬁc characteristics. These characteristics are
subdivided into the following groups: general information
(such as oligopeptide name or accession number), organismic
classiﬁcation (including multiple trivial species names),
physicochemical properties (such as partial amino acid
sequences), biochemical or biologic functions and literature
references. Query examples (single words, phrases or
numbers) are provided adjacent to each Query window, and
pull-down menus are provided with most query options. An
‘Abbreviations’ button, located near the Query window for
amino acid sequence, elicits display of the standard one-
letter code for amino acid residues, along with optional
abbreviations.
Because some oligopeptides, particularly the smallest ones,
are chemically modiﬁed at the N- and C-termini, six more
symbols augment the standard one-letter code. These are:
(i) ‘+’ to denote
+H2, which is the open N-terminus,
(ii) ‘b’ for an acetyl residue or other chemical group at the
N-terminus,
(iii) ‘ ’ to denote O
 , which is the open C-terminus,
(iv) ‘z’ for an amide bond at the C-terminus,
(v) ‘J’ to denote the pyroglutaminyl linkage, formed by an
N-terminal glutamine, owing to side-chain reaction with
the terminal amine residue (13,14), and finally,
(vi) ‘U’ for the (occasional) aminoisobutyric acid residue.
Results page
After entering a search word or phrase on the Query page, the
user should click on the ‘Submit query’ button, which initiates
the search and returns with the Results page, containing a
list of oligopeptides that meet the speciﬁed characteristics.
Each item in this list will contain the preferred name of
oligopeptide, the trivial and taxonomic names of organisms
where the peptide has been identiﬁed, and the accession num-
ber. The accession number, in turn, links to the appropriate
Peptide page (record). When the query returns only a single
oligopeptide, its record opens immediately.
Peptide page
This page, reached via accession number, presents the
collected data on each oligopeptide, including the number
of amino acid residues, primary structure, precursors, known
posttranslational modiﬁcation(s), afﬁnity to any deﬁnite
structure–function family, taxon(s) of biological sources,
tissue/cell localization in each organism, major known bio-
logical functions, molecular mass (Da), isoelectric point, pI
(calculated and experimentally observed), literature sources
and linking accession numbers (if any) in other peptide-
protein databases (see above) or PubMed.
Family page
Tentative homologous family assignments, for each oligo-
peptide in EROP-Moscow, have been developed by sequence
alignment, and the entire family can be reached from the
Peptide page via a ‘View family’ button. Equally located
amino acid residues are highlighted in red and the attached
oligopeptide name for each sequence links back to the appro-
priate Peptide page.
Statistics pages
A special set of pages is devoted to the overall characteristics
of data on oligopeptides listed in EROP-Moscow. The starting
Statistics page is reached from Home page via the ‘EROP
Statistics’ button, and it contains the list of statistical para-
meters compiled, each named parameter being a link to one
of 15 additional Statistics pages (pp. 1–10.2). These in turn
present graphic and tabular information on oligopeptides
currently available in EROP-Moscow, information including:
(i) a chronological diagram, by years, for decoding
chemical structures of new oligopeptides (Figure 2),
(ii) size distribution of oligopeptides (number of amino acid
residues; Figure 3),
(iii) current numerical yield of oligopeptides per taxonomic
group,
(iv) total amino acid residue content of all listed
oligopeptides,
(v) relative contributions of international scientists, by
home country, to the discovery of new oligopeptide
structures,
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(>500),
(vii) functional classes of oligopeptides ( 100),
(viii) primary literature sources (>300), and
(ix) authors of the original publications devoted to decoding
of oligopeptide chemical structures (>8000).
This statistical information demonstrates, for example, that
the greatest number of natural oligopeptides have been
identiﬁed in humans, especially in the human brain; to date
neuropeptides represent the single largest functional class.
The data also show that the most proliﬁc journal for publi-
cation of new oligopeptides is the Journal of Biological
Figure 3. Distribution of known oligopeptides by amino acid residue number (Statistics page 2).
Figure 2. Increase in the number of decoded amino acid sequences of the natural oligopeptides (Statistics page 1).
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J. M. Conlon, leads the discovery of new oligopeptides.
SERVICE MODULES
The EROP-Moscow database accesses a set of special soft-
ware tools for alignment, and for calculating molecular masses
and isoelectric points. These operations are executed outside
the EROP-Moscow site, and results are returned to EROP-
Moscow (as a part of its update capability) and displayed on
the Peptide page and the Family page.
This system creates dynamic web pages using cgi-scripts
written in the PHP language. In response to each appropriate
user query, the required HTML-pages are generated inter-
actively. Once the user’s web browser has sent the HTTP
query to the web server, the required script containing the
database query isexecuted.Afterthe surveyofneededrecords,
the PHP script dynamically generates the results, in the form
of an HTML-page sent to the user’s computer.
Graphic information is also generated and plotted
dynamically, e.g. in the statistical processing of data, thus
permitting online display of statistical summaries for all nat-
ural oligopeptides currently available in the EROP-Moscow
database.
COMPARISON OF EROP-MOSCOW WITH OTHER
PEPTIDE–PROTEIN DATABASES
The internet now provides free access to a large number of
both generalized and specialized peptide-protein databases.
Best known among the generalized databases are PIR (15)
and Swiss-Prot (Swiss Protein), which is linked with the data-
base of amino acid sequences translated from nucleotides
TrEMBL (Translated, European Molecular Biology Laborat-
ory) (16). Smaller databases, containing information about
selected classes of oligopeptides, include Peptaibol (Peptide
aminoisobuturic, for data on peptides possessing at least one
residue of aminoisobutyric acid) (17), ANTIMIC (ANTIMI-
Crobial, concerned with antimicrobial peptides) (18) and
SCORPION (19), especially created for the peptide-protein
toxins from a single order of arachnoids, the scorpions.
About half the natural oligopeptide structures now available
in EROP-Moscow, however, are absent from the above-
named databases, for several reasons, especially (i) that little
attention is paid to oligopeptides formed by means of non-
ribosomal or pure enzymatic synthesis, and (ii) that precursor-
product series are not handled systematically. In particular,
very many oligopeptides generated as natural fragments of
large precursors are not speciﬁcally indexed in the above
databases and can be found there only by their amino acid
sequences. Swiss-Prot contains one record (P01019), e.g. on
human angiotensinogen, which includes the amino acid
sequencesforangiotensinsIandII(20),butomits angiotensins
V and VI (21). EROP-Moscow containsthese (recordsE00165
and E00166), as well as the more familiar oligopeptides.
In addition, EROP-Moscow lists a considerable number
of oligopeptides with unique amino acid sequences that are
simply not included in the other databases—owing either to
the source journals (e.g. Biological Bulletin) being out of view
of most database managers, or to failure in tracing primary
sources keyed from secondary publications.
Information on very short oligopeptides is particularly
deﬁcient in the other major databases. Table 1 displays
a useful comparison of these (di- to hepta-) peptides in
EROP-Moscow, versus Swiss-Prot.
CONCLUDING REMARKS
The database EROP-Moscow has been developed for simple
and rapid retrieval of information on natural regulatory oligo-
peptides and their structurally homologous families. In addi-
tion to solving true informational problems, EROP-Moscow
can serve as a basis for new research and for elucidating
general principles of structural and functional organization
for these substances. For example, the current size distribution
of oligopeptides, by number of amino acid residues (Figure 3),
shows a numerical peak  8–10 residues, but this peak has
no proper rationale at present. Study of structurally homo-
logous families should facilitate prediction of the functional
properties of newly found oligopeptide molecules, should pro-
vide bases for classifying newly discovered molecules and in
turn should promote creation of novel, highly efﬁcient phar-
maceutics derived from the natural regulatory oligopeptides.
Because the discovery of new regulatory oligopeptides is
a vigorous and continuing process (Figure 2), continuous
revision and upgrading of EROP-Moscow will be essential.
In this cause, we would ask users of EROP-Moscow to
alert us to newly discovered oligopeptides which may not
yet have been entered into the EROP-Moscow database.
For this purpose, the Contact-us button on Home page should
be convenient.
CITING EROP-MOSCOW
Users of the EROP-Moscow database are asked to cite this
paper, in their relevant published research.
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Table 1. Comparison of numbers of oligopeptides (from 2 to 7 amino acids)
contained in Swiss-Prot/TrEMBL (Release of July 19, 2005) and EROP-
Moscow (Release of May 17, 2005)
Amino acid residue Oligopeptide number
number Swiss-Prot-TrEMBL EROP-Moscow
2 1 120
36 7 1
42 5 9 0
5 28 120
6 19 139
7 106 232
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